Go-to-Market
A strong device can still lose momentum with a poorly executed launch. We help you turn strategy into launch plans and marketing programs that drive adoption.
Please feel out the form below and someone from our team will contact you shortly.

Overview
Go-to-market programs bring your commercial strategy to the audiences who will adopt, recommend, and purchase your device. We help biomedical innovators define their brand position, plan a coordinated launch, and deliver the education and marketing programs that build demand with clinicians and patients.
What go-to-market covers
Go-to-market programs turns commercial strategy into market traction. Our work helps you position your device clearly, launch with coordination across every audience, and build lasting demand.
-
Brand Strategy
Brand architecture, brand messaging, and value-based positioning.
-
Launch Planning
Launch readiness assessments, roadmaps, launch KPIs, scenario plans, and integrated launch plans.
-
Clinical Education
Budget impact, cost, and economic value models that demonstrate value to payers and health systems.
-
Marketing Programs
Digital and social programs, content marketing, demand generation, and sales enablement, with AI-enabled playbooks you can run with your own tools.
-
Patient Engagement
Patient engagement strategies and clinical trial recruitment and retention programs.
Where go-to-market shows up
Go-to-market should begin with brand positioning at Foundation and build toward launch. It leads from Market Clearance onward, when the brand, sales team, and clinical messaging must perform together.
PHASE 0
Foundation
Supports brand strategy and positioning for early stakeholders.
PHASE 1
Clinical Evidence
Supports clinical trial recruitment and retention programs.
PHASE 2
Pivotal Development
Supports brand architecture, finalized ahead of data readout.
PHASE 3
Regulatory Submission
Supports launch planning and readiness while the submission is under review.
PHASE 4
Market Clearance
Leads launch readiness and sales team preparation.
PHASE 5
Commercial Launch
Leads launch execution, clinical education, and marketing programs.
PHASE 6
Growth
Leads ongoing marketing programs and brand investment.
The ROI on better go-to-market programs
Launch is the moment of greatest visibility and greatest operational pressure. A coordinated go-to-market plan protects your commercial momentum and accelerates adoption with clinicians and patients.
Clear Market Position
A brand and message that differentiate your device with every audience.
Coordinated Launch
Sales, clinical, and marketing teams ready to perform together.
Faster Adoption
Education and marketing programs that build clinician and patient demand.
Sustained Growth
Programs your team can run and scale with its own tools.
Explore our disciplines
Every program draws on a different combination of our core disciplines to build the path from innovation to adoption.
-
Commercial Strategy
Choose the right market, define a differentiated position, and confirm the opportunity justifies the investment
-
Market Access
Build the path to payment and purchase, from coding and coverage to contracts.
-
Evidence & Insights
Ground commercial decisions in what clinicians, payers, and buyers need to see.
-
Go-to-Market
Turn strategy into launch plans and marketing programs that drive adoption.